© 2021 MJH Life Sciences and HCPLive. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive. All rights reserved.
January 20, 2021
The longtime FDA expert assumes the role following the resignation of Stephen Hahn, MD.
The approval is the first indication for a new pathway of care—one which has been linked to reduced heart failure death and hospitalization.
January 18, 2021
Such scores could provide insight into the significant comorbidity rate of ADHD and other youth mood and emotional dysregulation issues.
January 17, 2021
Personalized, daily self-reporting for patients could influence future therapeutic strategies.